Valuation Northeast Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 08/09/2026			5-day change	1st Jan Change
4.930 ^CNY	+2.49%		+0.61%	-5.56%

24/08	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
16/06	Northeast Pharmaceutical Group Co., Ltd. Announces Final Cash Dividend on A Shares for 2025, Payable on 23 June 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	6,848	8,384	9,051	7,646	7,531	7,449
Change	-	22.43%	7.95%	-15.52%	-1.5%	-1.09%
Enterprise Value (EV) ¹	7,967	8,322	7,403	4,178	4,656	5,959
Change	-	4.45%	-11.04%	-43.57%	11.44%	27.99%
P/E	507x	88.9x	25.2x	21.4x	18.2x	29x
PBR	1.72x	2.02x	1.99x	1.53x	1.42x	1.35x
PEG	-	0x	0x	-	1.1x	-0.8x
Capitalization / Revenue	0.93x	1.03x	1.03x	0.93x	1x	1.05x
EV / Revenue	1.08x	1.02x	0.84x	0.51x	0.62x	0.84x
EV / EBITDA	11.6x	11.6x	9.9x	4.62x	4.57x	7.76x
EV / EBIT	37.3x	39.5x	33.7x	11.4x	9.78x	23.1x
EV / FCF	21.7x	6.29x	6.2x	2.52x	-20.7x	-4.81x
FCF Yield	4.6%	15.9%	16.1%	39.7%	-4.84%	-20.8%
Dividend per Share ²	0.008	0.014	0.1	0.1	0.1	0.055
Rate of return	0.16%	0.23%	1.58%	1.87%	1.9%	1.05%
EPS ²	0.01	0.07	0.25	0.25	0.29	0.18
Distribution rate	80%	20%	40%	40%	34.5%	30.6%
Net sales ¹	7,384	8,145	8,809	8,243	7,503	7,075
EBITDA ¹	688.6	715.8	747.7	904.6	1,019	767.9
EBIT ¹	213.6	210.6	219.6	366.2	476	258.2
Net income ¹	12.26	99.03	350.1	358.5	409.8	260.1
Net Debt ¹	1,119	-62.17	-1,647	-3,468	-2,876	-1,491
Reference price ²	5.070	6.220	6.310	5.350	5.270	5.220
Nbr of stocks (in thousands)	13,50,702	13,47,873	14,34,316	14,29,103	14,29,103	14,27,088
Announcement Date	16/03/21	30/03/22	29/03/23	29/03/24	02/04/25	02/04/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
NORTHEAST PHARMACEUTICAL GROUP CO., LTD.	-	-	-	-	102.26Cr
ELI LILLY AND COMPANY	32.72x	11.9x	24.26x	0.6%	1,02400Cr
JOHNSON & JOHNSON	30.62x	-	-	1.95%	66TCr
ABBVIE INC.	32.73x	7.6x	15.8x	2.67%	45TCr
ROCHE HOLDING AG	19.22x	4.69x	11.6x	2.83%	35TCr
NOVARTIS AG	22.02x	5.68x	14.1x	2.82%	29TCr
ASTRAZENECA PLC	20.97x	4.3x	12.3x	2.05%	25TCr
AMGEN INC.	27.66x	7.14x	13.16x	2.31%	24TCr
NOVO NORDISK A/S	13.33x	4.82x	10.06x	3.78%	21TCr
GILEAD SCIENCES, INC.	-46.14x	6.65x	25.95x	2.18%	19TCr
Average	17.01x	6.60x	15.90x	2.35%	36.68TCr
Weighted average by Cap.	23.94x	7.98x	17.77x	1.96%